Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss.  GLP-1 medications were originally intended to ...
The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...
Hanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...
The podcast features Numerator Chief Economist Leo Feler, who talks about the potential impact of GLP-1 drugs like Ozempic ...
The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.
Eli Lilly trims Q4 guidance but maintains optimism with promising drugs like Zepbound for sleep apnea and global launches ...
There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its sales view.
After much international hype, weight management drug Wegovy has been offered at the GHA for a number of months. Speaking on Gibraltar Today, Dr Alfonso Antequera said the drug is effective for people ...
If you came here wondering what prediabetes means, we’ll answer it simply: Prediabetes, often considered the step before ...